nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—POR—malignant glioma	0.963	1	CbGaD
Nitrofurantoin—Fibrosis—Carmustine—malignant glioma	0.00353	0.0943	CcSEcCtD
Nitrofurantoin—Lung infiltration—Carmustine—malignant glioma	0.00215	0.0575	CcSEcCtD
Nitrofurantoin—Interstitial pneumonia—Temozolomide—malignant glioma	0.00202	0.0539	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Carmustine—malignant glioma	0.00143	0.0381	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Temozolomide—malignant glioma	0.00138	0.0368	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Temozolomide—malignant glioma	0.000916	0.0245	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Carmustine—malignant glioma	0.000843	0.0225	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000751	0.02	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000638	0.017	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000625	0.0167	CcSEcCtD
Nitrofurantoin—Renal failure—Carmustine—malignant glioma	0.000555	0.0148	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Carmustine—malignant glioma	0.000554	0.0148	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000541	0.0144	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Temozolomide—malignant glioma	0.000535	0.0143	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Carmustine—malignant glioma	0.000505	0.0135	CcSEcCtD
Nitrofurantoin—Hepatitis—Temozolomide—malignant glioma	0.00049	0.0131	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Temozolomide—malignant glioma	0.000488	0.013	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Temozolomide—malignant glioma	0.000463	0.0124	CcSEcCtD
Nitrofurantoin—Alopecia—Carmustine—malignant glioma	0.000448	0.012	CcSEcCtD
Nitrofurantoin—Chills—Temozolomide—malignant glioma	0.00044	0.0117	CcSEcCtD
Nitrofurantoin—Alopecia—Temozolomide—malignant glioma	0.000433	0.0116	CcSEcCtD
Nitrofurantoin—Anaemia—Carmustine—malignant glioma	0.000408	0.0109	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Temozolomide—malignant glioma	0.000396	0.0106	CcSEcCtD
Nitrofurantoin—Leukopenia—Carmustine—malignant glioma	0.000395	0.0105	CcSEcCtD
Nitrofurantoin—Anaemia—Temozolomide—malignant glioma	0.000394	0.0105	CcSEcCtD
Nitrofurantoin—Malaise—Temozolomide—malignant glioma	0.000385	0.0103	CcSEcCtD
Nitrofurantoin—Vertigo—Temozolomide—malignant glioma	0.000383	0.0102	CcSEcCtD
Nitrofurantoin—Leukopenia—Temozolomide—malignant glioma	0.000382	0.0102	CcSEcCtD
Nitrofurantoin—Chest pain—Carmustine—malignant glioma	0.000376	0.01	CcSEcCtD
Nitrofurantoin—Myalgia—Carmustine—malignant glioma	0.000376	0.01	CcSEcCtD
Nitrofurantoin—Cough—Temozolomide—malignant glioma	0.000372	0.00994	CcSEcCtD
Nitrofurantoin—Confusional state—Carmustine—malignant glioma	0.000363	0.0097	CcSEcCtD
Nitrofurantoin—Myalgia—Temozolomide—malignant glioma	0.000363	0.00969	CcSEcCtD
Nitrofurantoin—Discomfort—Temozolomide—malignant glioma	0.000359	0.00958	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Carmustine—malignant glioma	0.000353	0.00942	CcSEcCtD
Nitrofurantoin—Confusional state—Temozolomide—malignant glioma	0.000351	0.00937	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Temozolomide—malignant glioma	0.000348	0.00929	CcSEcCtD
Nitrofurantoin—Anorexia—Carmustine—malignant glioma	0.000343	0.00917	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Temozolomide—malignant glioma	0.000341	0.0091	CcSEcCtD
Nitrofurantoin—Anorexia—Temozolomide—malignant glioma	0.000332	0.00886	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000328	0.00876	CcSEcCtD
Nitrofurantoin—Paraesthesia—Carmustine—malignant glioma	0.000324	0.00864	CcSEcCtD
Nitrofurantoin—Dyspnoea—Carmustine—malignant glioma	0.000321	0.00857	CcSEcCtD
Nitrofurantoin—Somnolence—Carmustine—malignant glioma	0.00032	0.00855	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000317	0.00847	CcSEcCtD
Nitrofurantoin—Decreased appetite—Carmustine—malignant glioma	0.000313	0.00836	CcSEcCtD
Nitrofurantoin—Paraesthesia—Temozolomide—malignant glioma	0.000313	0.00834	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Carmustine—malignant glioma	0.000311	0.0083	CcSEcCtD
Nitrofurantoin—Dyspnoea—Temozolomide—malignant glioma	0.00031	0.00829	CcSEcCtD
Nitrofurantoin—Somnolence—Temozolomide—malignant glioma	0.00031	0.00826	CcSEcCtD
Nitrofurantoin—Constipation—Carmustine—malignant glioma	0.000308	0.00822	CcSEcCtD
Nitrofurantoin—Dyspepsia—Temozolomide—malignant glioma	0.000307	0.00818	CcSEcCtD
Nitrofurantoin—Decreased appetite—Temozolomide—malignant glioma	0.000303	0.00808	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000301	0.00802	CcSEcCtD
Nitrofurantoin—Constipation—Temozolomide—malignant glioma	0.000298	0.00795	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Carmustine—malignant glioma	0.000297	0.00792	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Carmustine—malignant glioma	0.000295	0.00786	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Temozolomide—malignant glioma	0.000287	0.00766	CcSEcCtD
Nitrofurantoin—Body temperature increased—Carmustine—malignant glioma	0.000285	0.0076	CcSEcCtD
Nitrofurantoin—Abdominal pain—Carmustine—malignant glioma	0.000285	0.0076	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000285	0.0076	CcSEcCtD
Nitrofurantoin—Abdominal pain—Temozolomide—malignant glioma	0.000275	0.00735	CcSEcCtD
Nitrofurantoin—Body temperature increased—Temozolomide—malignant glioma	0.000275	0.00735	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Carmustine—malignant glioma	0.000265	0.00709	CcSEcCtD
Nitrofurantoin—Asthenia—Carmustine—malignant glioma	0.000259	0.0069	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Temozolomide—malignant glioma	0.000257	0.00685	CcSEcCtD
Nitrofurantoin—Asthenia—Temozolomide—malignant glioma	0.00025	0.00667	CcSEcCtD
Nitrofurantoin—Diarrhoea—Carmustine—malignant glioma	0.000247	0.00658	CcSEcCtD
Nitrofurantoin—Dizziness—Carmustine—malignant glioma	0.000238	0.00636	CcSEcCtD
Nitrofurantoin—Diarrhoea—Temozolomide—malignant glioma	0.000238	0.00636	CcSEcCtD
Nitrofurantoin—Dizziness—Temozolomide—malignant glioma	0.00023	0.00615	CcSEcCtD
Nitrofurantoin—Vomiting—Carmustine—malignant glioma	0.000229	0.00611	CcSEcCtD
Nitrofurantoin—Rash—Carmustine—malignant glioma	0.000227	0.00606	CcSEcCtD
Nitrofurantoin—Headache—Carmustine—malignant glioma	0.000226	0.00602	CcSEcCtD
Nitrofurantoin—Vomiting—Temozolomide—malignant glioma	0.000221	0.00591	CcSEcCtD
Nitrofurantoin—Rash—Temozolomide—malignant glioma	0.00022	0.00586	CcSEcCtD
Nitrofurantoin—Headache—Temozolomide—malignant glioma	0.000218	0.00582	CcSEcCtD
Nitrofurantoin—Nausea—Carmustine—malignant glioma	0.000214	0.00571	CcSEcCtD
Nitrofurantoin—Nausea—Temozolomide—malignant glioma	0.000207	0.00552	CcSEcCtD
